Clinical Trials

Study of Immunotherapy to Treat Advanced Prostate Cancer

Location:

Trial status:

Inactive

Why is this study being done?

The purpose of the study is to determine if advanced prostate cancer patient s that are treated with radiotherapy (RT) plus ipilimumab live longer that those treated with RT alone

Who is eligible to participate?

Inclusion Criteria:

- Advanced prostate cancer

- At least 1 bone metastasis

- Testosterone < 50 ng/dl

- Prior treatment with docetaxel

Exclusion Criteria:

- Brain metastasis

- Autoimmune disease

- Known HIV, Hep B, or Hep C infection

- More than 2 prior systemic anticancer regimens for prostate cancer

- Prior treatment on BMS CA180227 for prostate cancer

Last updated: 11/07/2012

NCT ID:

NCT00861614